跳至主要内容
临床试验/ACTRN12620000156987
ACTRN12620000156987招募中1 期

The effect of propranolol on the metastatic niche in melanoma: A randomized controlled trial.

niversity of Queensland Diamantina Institute0 个研究点目标入组 24 人开始时间: 2020年2月13日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients newly diagnosed with a primary cutaneous melanoma that is ulcerated and/or thicker than 1mm (stage T1b – T4b, N0, M0 melanoma (2018 AJCC classification) and who elect to undergo a sentinel node biopsy procedure.

排除标准

  • Patients will be excluded if they (1) have clinical or imaging signs of regional or distant disease at diagnosis or (2) are currently prescribed any beta-blockers such as Propranolol or (3) have a contra-indication to beta-blockers or (4) are pregnant or (5) asthmatic.

研究者

发起方
niversity of Queensland Diamantina Institute

相似试验